Neurosteer develops a wearable, medical-grade EEG system designed to deliver real-time neural biomarkers in clinical settings. The company’s platform uses a compact sensor adhered to the head, enabling rapid deployment without traditional EEG caps or extensive setup. Its system combines disposable hardware with cloud-based analytics to support continuous neurological monitoring. Neurosteer positions its technology within regulated medical and clinical care environments.

The technology records EEG signals through a single-use, forehead-mounted sensor optimized for ease of use and signal stability. Neural data is transmitted to cloud-based systems where AI-driven algorithms extract biomarkers related to brain state, arousal, and neurological function. These biomarkers are generated in real time, enabling timely interpretation without manual EEG review. The platform emphasizes automation, scalability, and compatibility with existing clinical workflows.

Neurosteer targets applications in anesthesia monitoring, critical care, neurology, and cognitive assessment. The system is intended to support clinicians by providing objective, continuously updated neural metrics at the point of care. Its focus reflects broader efforts to operationalize EEG through simplified hardware and real-time analytics in routine medical practice.